Original news and analysis on international IP policy
World Health Organization Director General Margaret Chan today opened the 132nd meeting of the Executive Board, the UN agency’s highest authority, emphasising the importance of cost-effectiveness and results-driven operations at a time of global economic austerity and precarious funding.
The United States Federal Trade Commission, which keeps an eye out for anticompetitive behaviour, has issued a study finding that in 2012, a record number of deals were struck between brand-name and generic drug companies to keep the lower-priced generics off the market. Such deals, which arise from patent disputes, cost American consumers billions of dollars annually while piling on the federal deficit, it said.
The European Patent Office has announced that it reached new records in 2012 for patent filings and patents granted, according to preliminary figures. The United States remained at top, but growth was fastest in Asia, while European filings remained stable, it said.
In 2011, Margaret Chan, director general of the World Health Organization, launched a major reform of the United Nations organisation. This week, a presentation and discussions around the WHO reform by Gaudenz Silberschmidt, senior adviser in the WHO Office of the Director-General, highlighted the reason for this reform, its organisation and the possible impact the reform could have on the relationship between the pharmaceutical industry and the WHO.
A new innovation platform launched yesterday by Syngenta, the international agri-business company, means to broaden availability to some patented traits and technologies for vegetables, but also aims at opening new ways to use the intellectual property system.
Although pressure on internet service providers and other online companies to stop digital infringement isn't likely to abate this year, the current focus on enforcement appears to be giving way to a broader debate about how to resolve long-standing copyright issues to the benefit of users and the global economy. Talks continue in the World Intellectual Property Organization and elsewhere on exceptions and limitations, as the Trans-Pacific Partnership Agreement remains controversial.
The United States Senate Judiciary Committee in 2013 will address topical issues of gun violence and immigration, but will also take up issues of citizens' civil liberties in light of ever-increasing security measures, and a push for government transparency, freedom of the press, digital rights, access to books for the visually impaired, and incentives for innovation.
The World Health Organization reports that unprecedented progress has been made in addressing 17 parasitic diseases affecting the world’s poorest populations. The public health authority attributes the gains, in large part, to the contributions of global partners, including drug contributions made by research-based pharmaceutical giants.
The Corporate Europe Observatory and the European Commission presented their arguments in a case over access to documents about the EU-India free trade agreement before the General Court of the European Union in Luxembourg last Friday.
A Virginia-based company in the midst of a multi-million dollar merger is asserting patents on fundamental aspects of social networking it says have been infringed by Facebook, LinkedIn and three other companies. But even if the patents have validity, they come at a time of what may be a backlash against such lawsuits.
Unitaid, the drug purchasing facility affiliated with the UN World Health Organization, has won the rights to a series of internet domain names using its name, including unitaid.org. A World Intellectual Property Organization dispute panel found the names had been registered by a private party with the apparent intent of demanding a significant payment from the well-funded Unitaid.
Intellectual property owners in the United States may be happy to see the end of 2012. Among the notable setbacks they suffered last year: Congress refused to expand remedies against online infringement, the Supreme Court raised the bar for patentable inventions, and lower courts repeatedly denied injunctions against patent infringement. It is unclear, however, if IP owners will fare better in 2013.